A study for a 22 year old woman who takes Humira, Nuvaring - from FDA reports


Summary

78 females aged 22 (±5) who take the same drugs are studied. This is a personalized study for a 22 year old female patient who has Crohn's Disease, Birth Control. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Dec, 31, 2017

78 females aged 22 (±5) who take Humira, Nuvaring are studied.


Number of reports submitted per year:

Humira, Nuvaring for a 22-year old woman.

Information of the patient in this study:

  • Age: 22
  • Gender: female
  • Conditions: Crohn's Disease, Birth Control
  • Drugs taken:
    • Humira (adalimumab)
    • Nuvaring (ethinyl estradiol; etonogestrel)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Breast Engorgement: 0 (0% of females aged 22 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • injection site pain
  • injection site erythema
  • rashes
  • abdominal pain upper
  • gestational diabetes
  • hair loss
  • injection site pruritus
  • arthritis
  • polyhydramnios
  • thrombosis
1 - 6 months:
  • polyhydramnios
  • gestational diabetes
  • drug ineffective
  • thrombosis
  • colitis
  • itching
  • leukoplakia oral
  • fever
  • local swelling
  • injection site erythema
6 - 12 months:
n/a
1 - 2 years:
  • psoriasis
  • malaise
  • gingival bleeding
  • gingival disorder
  • itching
  • gingival pain
2 - 5 years:
  • tooth abscess
  • gastrointestinal motility disorder
  • intestinal stenosis
  • intestinal mucosal hypertrophy
  • fever
  • viral infection
  • skin exfoliation
  • nasopharyngitis
  • fungal infection
  • bronchitis
5 - 10 years:
  • intervertebral disc degeneration
  • back pain
  • intervertebral disc protrusion
10+ years:
n/a
not specified:
  • injection site pain
  • diarrhea
  • injection site erythema
  • fatigue
  • nasopharyngitis
  • cough
  • fever
  • urinary tract infection
  • rashes
  • headache

Top conditions involved for these people *:

  • Psoriasis (12 people, 15.38%)
  • Ulcerative Colitis (10 people, 12.82%)
  • Depression (5 people, 6.41%)
  • Pain (3 people, 3.85%)
  • Ankylosing Spondylitis (3 people, 3.85%)

Top co-used drugs for these people *:

  • Multivitamin (7 people, 8.97%)
  • Prednisone (6 people, 7.69%)
  • Bentyl (6 people, 7.69%)
  • Tramadol (5 people, 6.41%)
  • Promethazine (4 people, 5.13%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Humira, Nuvaring, Birth control Breast engorgement Crohn's disease

You may be interested in these posts

More posts for: Humira, Nuvaring, Birth control Breast engorgement Crohn's disease